Brief: Biofrontera Obtains Notice Of Allowance For U.S. Patent On Innovative Illumination Protocol
02/12/2021 13:43
Dec 2 (Reuters) - BIOFRONTERA AG B8FGn.DE :
* OBTAINS NOTICE OF ALLOWANCE FOR U.S. PATENT ON INNOVATIVE
ILLUMINATION PROTOCOL
* WILL START A PHASE III TRIAL FOR TREATMENT OF ACTINIC
KERATOSES
ON FACE AND SCALP WITH 3 TUBES OF AMELUZ® AND RHODOLED® XL LAMP
INVOLVING NEW PROTOCOL IN 2022
Source text for Eikon: ID:nPexCqYLNa
Further company coverage: B8FGn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million